Pediatric, Neonatal, and Adolescent Travelers

Travel Medicine: Second Edition

Volumn , Issue , 2008, Pages 223-233

  Summer, Andrea P ^a   Fischer, Philip R ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 68549131450     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-03453-1.10021-5     Document Type: Chapter

References (64)

1. Fischer P.R. Travel with infants and children. Infect Dis Clin North Am 1998, 12:355-368.
2. Summer A.P., Fischer P.R. Travel with infants and children. Clin Fam Pract 2005, 7:729-743.
3. Lanigan C., Wheeler M. Lonely Planet travel with children 2002, Lonely Planet, London. 4th edn.
4. Wilson-Howarth J., Ellis M. Your child's health abroad: a manual for travelling parents. Bucks: Bradt Publications 1998.
5. Center for Diseases Control and Prevention Health information for international travel 1999-2000 1999, DHHS, Atlanta, 212.
6. Parkins K.J., Poets C.F., O'Brien L.M., et al. Effect of exposure to 15% oxygen on breathing patterns and oxygen saturation in infants: interventional study. BMJ 1998, 316:887-894.
7. Committee on Injury and Poison Prevention Restraint use on aircraft. Pediatrics 2001, 108:1218-1222.
8. Csortan E., Jones J., Haan M., et al. Efficacy of pseudoephedrine for the prevention of barotrauma during air travel. Ann Emerg Med 1994, 23:1324-1327.
9. Buchanan B.J., Hoagland J., Fischer P.R. Pseudoephedrine and air travel-associated ear pain in children. Arch Pediatr Adolesc Med 1999, 153:466-468.
10. Hostetter M.K. Epidemiology of travel-related morbidity and mortality in children. Pediatr Rev 1999, 20:228-233.
11. Bull M.J., Sheese J. Update for the pediatrician on child passenger safety: five principles for safer travel. Pediatrics 2000, 106:1113-1116.
12. Biagioli F. Proper use of child safety seats. Am Fam Physician 2002, 65:2085-2090.
13. Takahashi M., Ogata M., Miura M. The significance of motion sickness in the vestibular system. J Vestib Res 1997, 7:179-187.
14. Lankamp D.J., Willemse J., Pikaar S.A., van Heyst A.N. Prochlorperazine in childhood: side-effects. Clin Neurol Neurosurg 1977, 80:264-271.
15. Orlowski J.P., Szpilman D. Drowning: rescue, resuscitation, and reanimation. Pediatr Clin North Am 2001, 48:627-646.
16. Hargarten S.W., Grenfell R.D. Travel-related injuries (motor vehicle crashes, falls, drownings): epidemiology and prevention. Textbook of travel medicine and health 2002, 371-375. Decker, London. 2nd edn. H.L. DuPont, R. Steffen (Eds.).
17. Hebert R.L., King G.E., Bent J.P. Tympanostomy tubes and water exposure: a practical model. Arch Otolaryngol Head Neck Surg 1998, 124:1118-1121.
18. Ackerman M.J., Tester D.J., Porter C.J. Swimminga, gene-specific arrhythmogenic trigger for inherited long QT syndrome. Mayo Clin Proc 1999, 74:1088-1094.
19. Committee on Sports Medicine and Fitness Medical conditions affecting sports participation. American Academy of Pediatrics 2001, 107:1205-1209.
20. Gloster H.M., Brodland D.G. The epidemiology of skin cancer. Derm Surg 1996, 22:217-226.
21. Kim H.J., Ghali F.E., Tunnessen W.W. Here comes the sun. Contemp Pediatr 1997, 14:41-69.
22. Coogan P.F., Geller A., Adams M., et al. Sun protection practices in preadolescents and adolescents: a school-based survey of almost 25,000 Connecticut school children. J Am Acad Derm 2001, 44:512-519.
23. Diffey B.L. When should sunscreen be reapplied?. J Am Acad Derm 2001, 45:882-885.
24. Durmowicz A.G. Recognizing high-altitude illnesses in children. J Resp Dis Pediatr 2002, 4:34-40.
25. Theis M.K., Honigman B., Yip R., et al. Acute mountain sickness in children at 2835 meters. Am J Dis Child 1993, 147:143-145.
26. Yaron M., Waldman N., Niermeyer S., et al. The diagnosis of acute mountain sickness in preverbal children. Arch Pediatr Adol Med 1998, 152:683-687.
27. Pollard A.J., Niermeyer S., Barry P., et al. Children at high altitude: an inter-national consensus statement by an ad hoc committee of the International Society for Mountain Medicine. 12 March, 2001. High Alt Med Biol 2001, 2:389-403.
28. West J.B. Consensus statement on children at high altitude. High Alt Med Biol 2001, 2:322-323.
29. Gamponia M.J., Babaali H., Yugar F., et al. Reference values for pulse oximetry at high altitude. Arch Dis Child 1998, 78:461-465.
30. DeMeer K., Heymans H.S., Zijlstra W.G. Physical adaptation of children to life at high altitude. Eur J Pediatr 1995, 154:263-272.
31. Sui G.J., Liu Y.H., Cheng X.S., et al. Subacute infantile mountain sickness. J Pathol 1988, 155:161-170.
32. Khoury G.H., Hawes D.R. Primary pulmonary hypertension in children living at high altitude. J Pediatr 1963, 62:177-185.
33. Sime F., Banchero N. Penaloza, et al. Pulmonary hypertension in children born and living at high altitudes. Am J Cardiol 1963, 11:143-149.
34. Getts A.G., Hill H.F. Sudden infant death syndrome: incidence at various altitudes. Dev Med Child Neurol 1982, 24:61-68.
35. Brouillette R.T., Nixon G. Risk factors for SIDS as targets for public health campaigns. J Pediatr 2001, 139:759-761.
36. Arguin P.M., Krebs J.W., Mandel E., et al. Survey of rabies preexposure and postexposure prophylaxis among missionary personnel stationed outside the United States. J Travel Med 2000, 7:10-14.
37. Haley R.W., Fischer R.P. Commercial tattooing as a potentially important source of hepatitis C infection. Clinical epidemiology of 626 consecutive patients unaware of their hepatitis C serologic status. Medicine (Baltimore) 2001, 80:134-151.
38. American Academy of Pediatrics Report of the Committee on Infectious Disease. 26th edn. 2003 Red Book 2003, Elk Grove Village: American Academy of Pediatrics. L.K. Pickering (Ed.).
39. American Academy of Pediatrics Recommended childhood immunization schedule - United States. Pediatrics 2006 2006, 117:239-240.
40. Fischer P.R., Bialek R. Prevention of malaria in children. Clin Infect Dis 2002, 34:493-498.
41. Fradin M.S. Mosquitoes and mosquito repellents: a clinician's guide. Ann Intern Med 1998, 128:931-940.
42. Qui H., Jun H.W., McCall J.W. Pharmacokinetics, formulation, and safety of insect repellent N,N-diethyl-3-methylbenzamide (DEET): a review. J Am Mosq Control Assoc 1998, 14:12-27.
43. Fradin M.S., Day J.F. Comparative efficacy of insect repellents against mosquito bites. New Engl J Med 2002, 347:13-18.
44. Fischer P.R., Christenson J.C., Concentrated D.E.E.T. Safe - and sometimes necessary. Contemp Pediatr 1998, 15:28.
45. US Environmental Protection Agency EPA promotes safer use of insect repellent DEET (press release 24 April) 1998, US Environmental Protection Agency, Washington, DC.
46. Weil W.B. New information leads to changes in DEET recommendations. AAP News 2001, (Aug):52-53.
47. Badolo A., Ilboudo-Sanogo E., Ouedraogo A., Costantini C. Evaluation of the sensitivity of Aedes aegypti and Anopheles gambiae complex mosquitoes to two insect repellents: DEET and KBR 3023. Trop Med Int Health 2004, 9:330-334.
48. Frances S.P., N Van Dung, Beebe N.W., Debboun M. Field evaluation of repellent formulations against daytime and nighttime biting mosquitoes in a tropical rainforest in northern Australia. J Med Entomol 2002, 39:541-544.
49. EPA. Online. Available: (accessed Oct 27, 2005). http://www.epa.gov/opprd001/factsheets/picaridin.pdf.
50. Wilson M.E. Prevention of tick-borne diseases. Med Clin North Am 2002, 86:219-238.
51. Poland G.A. Prevention of Lyme disease: a review of the evidence. Mayo Clin Proc 2001, 76:713-724.
52. Stauffer W.M., Konop R.J., Kamat D. Traveling with infants and young children. Part III: travelers' diarrhea. J Travel Med 2002, 9:141-150.
53. Pitzinger B., Steffen R., Tschopp A. Incidence and clinical features of travelers' diarrhea in infants and children. Pediatr Infect Dis J 1991, 10:719-723.
54. Provisional Committee on Quality Improvement Practice parameter: the management of acute gastroenteritis in young children. Pediatrics 1996, 97:424-433.
55. Duggan C., Nurko S. 'Feeding the gut': the scientific basis for continued enteral nutrition during acute diarrhea. J Pediatr 1997, 131:801-808.
56. Bowie M.D., Hill I.D., Mann M.D. Loperamide for treatment of acute diarrhoea in infants and young children. A double-blind placebo-controlled trial. S Afr Med J 1995, 85:885-887.
57. Kaplan M.A., Prior M.J., McKonly K.I., et al. A multicenter randomized controlled trial of a liquid loperamide product versus placebo in the treatment of acute diarrhea in children. Clin Pediatr (Phil) 1999, 38:579-591.
58. Markowitz J.E., Bengmark S. Probiotics in health and disease in the pediatric patient. Ped Clin North Am 2002, 49:127-141.
59. Wong C.S., Jelacic S., Habeeb R.L., et al. The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157: H7 infections. N Engl J Med 2000, 342:1930-1936.
60. Grady R.W. Systemic quinolone antibiotics in children: a review of the use and safety. Expert Opin Drug Saf 2005, 4:623-630.
61. DuPont H.L., Jiang Z., Ericsson C.D., et al. Rifaximin versus ciprofloxacin for the treatment of travelers' diarrhea: A randomized, double-blind clinical trial. Clin Infect Dis 2001, 33:1807-1815.
62. Steffen R., Sack D.A., Riopel L. Therapy of travelers' diarrhea with rifaximin on various continents. Am J Gastroenterol 2003, 98:1073-1078.
63. Taylor D.N. Poorly absorbed antibiotics for the treatment of travelers' diarrhea. 2005, 41:S564-S570.
64. Fischer P.R., Christenson J.C., Pavia A.T. Pediatric problems during and after international travel. Travel medicine advisor 1998, 9-18. American Health Consultants, Atlanta, TC2. F.J. Bia (Ed.).